Edwin Ardiansyah

Edwin Ardiansyah

Auto-generated profile, based on publicly available information

Edwin Ardiansyah

Research Center for Care and Control of Infectious Diseases, Universitas Padjadjaran , Bandung

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2023 in eLife
Verified
Journal Article
Open access
EAEdwin Ardiansyah
Edwin Ardiansyah
JAJulian Avila-Pacheco
Julian Avila-Pacheco
LNLe Thanh Hoang Nhat
Le Thanh Hoang Nhat
SDSofiati Dian
Sofiati Dian
DVDao Nguyen Vinh
Dao Nguyen Vinh
NTNguyen Thuy Thuong Thuong
Nguyen Thuy Thuong Thuong
Background: Cellular metabolism is critical for the host immune function against pathogens, and metabolomic analysis may help understand the characteristic immunopathology of tuberculosis. We performed targeted metabolomic analyses in a large cohort of patients with tuberculous meningitis (TBM), the most severe manifestation of tuberculosis, focusing on tryptophan metabolism.Methods: We studied 1069 Indonesian and Vietnamese adults with TBM (26.6% HIV-positive), 54 non-infectious controls, 50 with bacterial meningitis, and 60 with cryptococcal meningitis. Tryptophan and downstream metabolites were measured in cerebrospinal fluid (CSF) and plasma using targeted liquid chromatography–mass spectrometry. Individual metabolite levels were associated with survival, clinical parameters, CSF bacterial load and 92 CSF inflammatory proteins.Results: CSF tryptophan was associated with 60-day mortality from TBM (hazard ratio [HR] = 1.16, 95% confidence interval [CI] = 1.10–1.24, for each doubling in CSF tryptophan) both in HIV-negative and -positive patients. CSF tryptophan concentrations did not correlate with CSF bacterial load nor CSF inflammation but were negatively correlated with CSF interferon-gamma concentrations. Unlike tryptophan, CSF concentrations of an intercorrelating cluster of downstream kynurenine metabolites did not predict mortality. These CSF kynurenine metabolites did however correlate with CSF inflammation and markers of blood–CSF leakage, and plasma kynurenine predicted death (HR 1.54, 95% CI = 1.22–1.93). These findings were mostly specific for TBM, although high CSF tryptophan was also associated with mortality from cryptococcal meningitis.Conclusions: TBM patients with a high baseline CSF tryptophan or high systemic (plasma) kynurenine are at increased risk of death. These findings may reveal new targets for host-directed therapy.Funding: This study was supported by National Institutes of Health (R01AI145781) and the Wellcome Trust (110179/Z/15/Z and 206724/Z/17/Z).

3 July 2025 in Brain Communications
Verified
Journal Article
Open access
SDSofiati Dian
Sofiati Dian
VKValerie A C M Koeken
Valerie A C M Koeken
EAEdwin Ardiansyah
Edwin Ardiansyah
AGAhmad R Ganiem
Ahmad R Ganiem
KAKirsten van Abeelen
Kirsten van Abeelen
VKVinod Kumar
Vinod Kumar
This study examines the role of host inflammation in the high mortality of tuberculous meningitis (TBM) and identifies potential biomarkers associated with improved survival. We conducted a case-control study involving 131 patients in a discovery cohort, 81 TBM patients in a validation cohort, and 43 non-infected controls from a referral hospital in Indonesia. We measured 94 inflammation-related proteins in cerebrospinal fluid (CSF) and performed genome-wide quantitative trait loci (QTL) mapping. Sixty-seven proteins were found to be differentially expressed between TBM patients and controls, with 64 proteins elevated in patients. Five proteins, including vascular endothelial growth factor (VEGF) and matrix metalloproteinase-10 (MMP-10), were identified as predictors of 180-day mortality in TBM patients. The validation cohort confirmed that MMP-10, but not VEGF, was predictive of mortality. Genome-wide QTL mapping identified two genome-wide significant and four suggestive genetic loci associated with CSF MMP-10, which also predicted survival in an additional cohort of 218 patients. High CSF concentrations of MMP-10, along with specific genetic loci, may be associated with survival in TBM patients, suggesting a potential role for MMP-10 in disease pathogenesis and warranting further investigation into its utility in host-directed therapies.

15 November 2024 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
SDSofiati Dian
Sofiati Dian
EAEdwin Ardiansyah
Edwin Ardiansyah
LCLidya Chaidir
Lidya Chaidir
ALArjan van Laarhoven
Arjan van Laarhoven
RRRovina Ruslami
Rovina Ruslami
RCReinout Van Crevel
Reinout Van Crevel
Hyponatremia is common in tuberculous meningitis (TBM), but its impact on disease severity and outcomes is unclear. In a cohort of 864 adult patients with TBM in Indonesia, we assessed the prevalence and prognostic significance of hyponatremia, classified as moderate (120–130 mEq/L) or severe (<120 mEq/L). Patients received standard antituberculous therapy and corticosteroids and were followed for 1-year mortality. Hyponatremia occured in 86.8% of patients, with 26% classified as severe. Severe hyponatremia associated with male, younger age, a lower Glasgow Coma Scale (GCS), and markers of more severe disease (P < .05). One-year mortality was 46.5% and associated with older age, HIV infection, lower GCS, markers of neurologic severity, fever, and thrombocytosis. Severe hyponatremia predicted mortality in univariate analysis showed no impact in HIV-positive patients. Hyponatremia reflects disease severity in TBM but does not independently predict mortality, suggesting limited benefit from agressive correction. This graphical abstract is also available at Tidbit: https://tidbitapp.io/tidbits/hyponatremia-in-tb-meningitis-4e62fd74-490f-4ccb-b9ab-00a4c7eecf8c

29 September 2026 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
LKLisa Kurver
Lisa Kurver
ETEefje Klein Teeselink
Eefje Klein Teeselink
SKSimon E Koele
Simon E Koele
NHNicolien Hanemaaijer
Nicolien Hanemaaijer
ALArthur Lemson
Arthur Lemson
ALArjan van Laarhoven
Arjan van Laarhoven
Background: “Paradoxical reactions” are a poorly understood phenomenon of clinical worsening during adequate antibiotic tuberculosis treatment. We aimed to characterize and predict paradoxical reactions using clinical, microbiological, and inflammatory factors in human immunodeficiency virus (HIV)–negative patients with pulmonary tuberculosis. Methods: We closely monitored HIV-negative patients aged ≥16 years who were admitted to a Dutch referral center. Paradoxical reactions were defined as new or increased tachypnea with hypoxemia or new or increased need for supplemental oxygen, after exclusion of alternative causes. Blood inflammatory parameters at onset of paradoxical reaction, and 1 and 2 weeks prior were matched for treatment duration to those of patients without paradoxical reactions and compared using Stouffer z scores. Baseline and longitudinal mycobacterial load, clinical parameters, chest radiographic involvement, and antibiotic plasma concentrations were assessed for association with paradoxical reactions. Results: Among 81 HIV-negative patients with pulmonary tuberculosis, 19 (24%) experienced a paradoxical reaction, after a median of 13 days of antituberculosis treatment (interquartile range, 8–18 days). Paradoxical reactions were characterized by higher C-reactive protein level (Stouffer z = 4.22), neutrophil count (z = 3.65), neutrophil-to-lymphocyte ratio (z = 4.94), and ferritin level (z = 4.12) and lower lymphocyte count (z = −3.26), monocyte count (z = −4.72), albumin level (z = −6.33), and hemoglobin level (z = −2.32). More extensive lung involvement and higher mycobacterial loads at initiation of antituberculosis treatment were associated with paradoxical reactions. Antituberculosis drug levels were adequate, and mycobacterial loads declined in both groups. High C-reactive protein and neutrophil-to-lymphocyte ratio and lymphopenia at initiation of antituberculosis treatment predicted paradoxical reactions. Conclusions: Paradoxical reactions in HIV-negative individuals with pulmonary tuberculosis concur with, and are preceded by, outspoken systemic inflammation. Baseline inflammatory parameters may guide future stratified preemptive immunomodulation.